Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07141537Recruiting

Caloric Balance Markers Study

Role: lead

NCT04082611Not ApplicableCompleted

The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition

Role: collaborator

NCT05081700Completed

A Systems Approach to Understanding Disease Processes in Multiple Sclerosis

Role: collaborator

NCT05923333Not ApplicableRecruiting

B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV

Role: collaborator

NCT03424200Not ApplicableCompleted

Coaching for Cognition in Alzheimer's (COCOA)

Role: collaborator

All 5 trials loaded